Author:
Robinson Dr.Andrew G.,Snow Stephanie,Brade Anthony,Ho Cheryl,Wheatley-Price Paul,Blais Normand,Cheema Parneet,Swaminath Anand
Reference57 articles.
1. Stage III non-small-cell lung cancer: population-based patterns of treatment in British Columbia, Canada;Vinod;J thoracic oncology: official publication of the International Association for the Study of Lung Cancer,2012
2. Stage III non-small-cell lung cancer: establishing a benchmark for the proportion of patients suitable for radical treatment;Al-Shamsi;Clin Lung Cancer,2014
3. Optimal managements of stage IIIA (N2) non-small cell lung cancer patients: a population-based survival analysis;Pang;J Thorac Dis,2017
4. Antonia S.J., Villegas A., Daniel D., Vicente D., Murakami S., Hui R., et al. Overall survival with Durvalumab after chemoradiotherapy in Stage III NSCLC. The New England J medicine. 2018. Epub 2018/10/04. doi: 10.1056/NEJMoa1809697. PubMed PMID: 30280658.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献